KYMR ▲ +4.6% - Kymera Therapeutics, Inc. $KYMR - Kymera Therapeutics to Announce KT-579 Phase 1 Healthy Volunteer Trial Results on October 29, 2026 28-OCT-2026 04:01 PM ET